Archive

Missed a briefing? Here you can find all our past issues.

Here's the $1.8 billion plan to get the data AI needs

Oct 8, 2026

•

6 min read

Here's the $1.8 billion plan to get the data AI needs

Plus: DeepMind’s made-to-order enzymes, Lilly’s animal data powering AI for smaller biotechs, and Utah’s test of AI-written acne prescriptions.

Peter Ottsjö

Superintelligence vs. clinical trials: The ultimate boss fight

Oct 5, 2026

•

6 min read

Superintelligence vs. clinical trials: The ultimate boss fight

Plus: Xaira’s antibodies succeed where earlier attempts failed, AI cell models get a fairer test, and Ortet launches with a $500 million commitment.

Peter Ottsjö

Solving all disease? Show us the evidence then.

Oct 1, 2026

•

6 min read

Solving all disease? Show us the evidence then.

Plus: Claude’s discovery challenged, DeepMind watermarks proteins, and $7.5 million for a robot surgeon.

Peter Ottsjö

AI runs this lab. The humans follow instructions.

Sep 28, 2026

•

4 min read

AI runs this lab. The humans follow instructions.

Plus: Jura upgrades the AI that manufactures its own DNA designs.

Peter Ottsjö

That was quick: Claude’s discovery has echoes of CRISPR

Sep 24, 2026

•

7 min read

That was quick: Claude’s discovery has echoes of CRISPR

Plus: Elizabeth Hudson on collecting the data biological AI needs, Minerva uncovers an unusual way nature makes DNA, and Enveda raises $311 million.

Peter Ottsjö

Navier-Stokes was child’s play. Biology is expert mode.

Sep 21, 2026

•

9 min read

Navier-Stokes was child’s play. Biology is expert mode.

Plus: China’s AI pharma masterplan, mRNA vaccines that survive 37°C, and what biological world models are still missing.

Peter Ottsjö

It's happening: Anthropic has built its own biology lab

Sep 19, 2026

•

8 min read

It's happening: Anthropic has built its own biology lab

Plus: Insilico’s AI takes on aging, Therna designs personalized RNA medicines, and DeepMind prepares for the AGI era.

Peter Ottsjö

Garage drug developer plans to be bigger than Pfizer

Sep 14, 2026

•

7 min read

Garage drug developer plans to be bigger than Pfizer

Plus: AlphaFold illuminates “superdark” proteins, Astra surprises chemists, and GenScript seeks $300M to expand its labs.

Peter Ottsjö

An AI-designed drug raises hopes of slowing aging

Sep 10, 2026

•

7 min read

An AI-designed drug raises hopes of slowing aging

Plus: Scientists build with Astra, DeepMind maps nine billion DNA changes, and David Baker co-leads a $95M effort to design new biology.

Peter Ottsjö

No human in the loop - AI gets certified to clear mammograms

Sep 3, 2026

•

6 min read

No human in the loop - AI gets certified to clear mammograms

Plus: Claude designs proteins but won’t discuss biology, a team of AIs takes on lung-cancer slides, and Om brings “vibe discovery” to Codex.

Peter Ottsjö

Archive

Missed a briefing? Here you can find all our past issues.

Here's the $1.8 billion plan to get the data AI needs

Superintelligence vs. clinical trials: The ultimate boss fight

Solving all disease? Show us the evidence then.

AI runs this lab. The humans follow instructions.

That was quick: Claude’s discovery has echoes of CRISPR

Navier-Stokes was child’s play. Biology is expert mode.

It's happening: Anthropic has built its own biology lab

Garage drug developer plans to be bigger than Pfizer

An AI-designed drug raises hopes of slowing aging

No human in the loop - AI gets certified to clear mammograms

BAIO